- Design of precise third-line therapy for gastric cancer: target or chemotherpy?
-
Cho JY
- KMID: 1776450
- Korean J Intern Med.
- 2013 May;28(3):297-299.
- doi: 10.3904/kjim.2013.28.3.297
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Synchronous Early Gastric Cancer and Diffuse Large B Cell Lymphoma Treated with Endoscopic Submucosal Dissection and Chemotherapy
-
Park JH, Jang JY, Cho YD, Dong SH, Kim HJ, Kim BH, Chang YW
- KMID: 1792838
- Korean J Gastroenterol.
- 2012 May;59(5):377-381.
- doi: 10.4166/kjg.2012.59.5.377
Among malignant tumors of the stomach, adenocarcinoma takes up about 95% and the remaining are mostly lymphomas, being less than 5%. The majority of lymphomas are B cell lymphomas, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer
-
Ryu JK
- KMID: 2373330
- Korean J Gastroenterol.
- 2015 Sep;66(3):150-153.
- doi: 10.4166/kjg.2015.66.3.150
Pancreatic adenocarcinoma is one of the fatalist malignancies. A large proportion of patients are diagnosed with unresectable stage pancreatic cancer at the time of presentation. Gemcitabine is a standard chemotherapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin and Leucovorin Plus Fluorouracil Versus Irinotecan and Leucovorin Plus Fluorouracil Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Adenocarcinoma
-
Kang SH, Kim JI, Moon HS, Kim SH, Sung JK, Lee BS, Jeong HY
- KMID: 1775923
- Korean J Gastroenterol.
- 2010 Jan;55(1):26-32.
- doi: 10.4166/kjg.2010.55.1.26
BACKGROUND/AIMS: We performed retrospective study in order to compare oxaliplatin, leucovorin, and fluorouracil (FOLFOX) versus irinotecan, leucovorin, and fluorouracil (FOLFIRI) in recurred or metastatic gastric adenocarcinoma. METHODS: We investigated 56 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells
-
Hong WS, Kim CM, Lee CT, Lee JO, Kang TW
- KMID: 1421919
- J Korean Med Sci.
- 1992 Sep;7(3):236-240.
- doi: 10.3346/jkms.1992.7.3.236
Recombinant human-interferon-gamma (rH-IFN-gamma) and verapamil (VRP), either alone or in combination, were evaluated in MTT assay for their modification effects on adriamycin-induced cytotoxicity against MKN-45, human stomach adenocarcinoma cells.... -
- CITED
-
- Close
- SHARE
-
- Close
- Tarantula cubensis extract alters the degree of apoptosis and mitosis in canine mammary adenocarcinomas
-
Gultiken N, Guvenc T, Kaya D, Agaoglu AR, Ay SS, Kucukaslan I, Emre B, Findik M, Schafer-Somi S, Aslan S
- KMID: 2164531
- J Vet Sci.
- 2015 Jun;16(2):213-219.
- doi: 10.4142/jvs.2015.16.2.213
In the present study, 13 clinical cases of canine mammary adenocarcinoma were evaluated in order to understand the effect of Tarantula cubensis extract (TCE) on tumor tissue. Punch biopsies were... -
- CITED
-
- Close
- SHARE
-
- Close
- Astaxanthin Inhibits Proliferation of Human Gastric Cancer Cell Lines by Interrupting Cell Cycle Progression
-
Kim JH, Park JJ, Lee BJ, Joo MK, Chun HJ, Lee SW, Bak YT
- KMID: 2411963
- Gut Liver.
- 2016 May;10(3):369-374.
- doi: 10.5009/gnl15208
BACKGROUND/AIMS: Astaxanthin is a carotenoid pigment that has antioxidant, antitumoral, and anti-inflammatory properties. In this in vitro study, we investigated the mechanism of anticancer effects of astaxanthin in gastric carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Heterogeneity of Adenosine Triphosphate-Based Chemotherapy Response Assay in Colorectal Cancer - Secondary Publication
-
Huh JW, Park YA, Lee KY, Sohn SK
- KMID: 1103825
- Yonsei Med J.
- 2009 Oct;50(5):697-703.
- doi: 10.3349/ymj.2009.50.5.697
PURPOSE: Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) is a well-documented and validated technology that can individualize chemotherapy for patients with lung, stomach, or breast cancer. This study explored the feasibility... -
- CITED
-
- Close
- SHARE
-
- Close
- Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
-
Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ
- KMID: 1776453
- Korean J Intern Med.
- 2013 May;28(3):314-321.
- doi: 10.3904/kjim.2013.28.3.314
BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum immunoglobulin fused interferon-alpha inhibited tumor growth in athymic mice bearing colon 26 adenocarcinoma cells
-
Kim JS, Yu KN, Noh MS, Woo MA, Park SJ, Park JH, Hua J, Cho HS, Hwang SK, Lee ES, Chung YS, Choi IY, Kwon SC, Cho MH
- KMID: 1102953
- J Vet Sci.
- 2008 Mar;9(1):45-50.
- doi: 10.4142/jvs.2008.9.1.45
Interferon (IFN) has therapeutic potential for a wide range of infectious and proliferative disorders. However, the half-life of IFN is too short to have a stable therapeutic effect. To overcome... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Tegafur-uracil Plus Folinic Acid versus Intravenous 5-fluorouracil Plus Folinic Acid as Adjuvant Chemotherapy of Colon Cancer
-
Kim DJ, Kim TI, Suh JH, Cho YS, Shin SK, Kang JK, Kim NK, Kim WH
- KMID: 720907
- Yonsei Med J.
- 2003 Aug;44(4):665-675.
- doi: 10.3349/ymj.2003.44.4.665
To compare, in terms of compliance, toxicity, quality of life (QOL) and efficacy, intravenous 5-fluorouracil plus folinic acid with oral tegafur-uracil plus folinic acid as postoperative adjuvant chemotherapy after curative... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
-
Jung M, Lee CH, Park HS, Lee JH, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Cho BC
- KMID: 2158218
- Yonsei Med J.
- 2013 Jul;54(4):854-864.
- doi: 10.3349/ymj.2013.54.4.854
PURPOSE: The main objective of this study was to evaluate the association between polymorphisms of the target genes of pemetrexed and clinical outcomes in non-small cell lung cancer (NSCLC) patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Adenocarcinoma of Unknown Primary Site
-
Song SY, Kim WS, Lee HR, Jung HS, Oh SY, Kim JH, Kim KH, Nam EM, Oh YR, Jung CW, Yoon SS, Im YH, Lee HG, Kang WK, Park CH, Park KC
- KMID: 759616
- Korean J Intern Med.
- 2002 Dec;17(4):234-239.
BACKGROUND: Metastatic cancer of unknown primary site occupies 0.5~10% of all diagnosed cancer patients and includes various tumors with diverse responses to systemic chemotherapy. Adenocarcinoma of unknown primary site... -
- CITED
-
- Close
- SHARE
-
- Close
- Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen
-
Chung HC, Roh JK, Park YJ, Lee SI, Min JS, Lee JT, Lee KB, Kim BS
- KMID: 1121425
- Yonsei Med J.
- 1990 Mar;31(1):74-79.
- doi: 10.3349/ymj.1990.31.1.74
The prognosis of unresectable advanced gastric cancer is extremely poor. We tried a neoadjuvant chemotherapy in locally advanced unresectable stomach cancer diagnosed by initial explo-laparotomy. After chemotherapy with the FADE... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
-
Hwang J, Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ
- KMID: 1785814
- J Korean Med Sci.
- 2008 Aug;23(4):586-591.
- doi: 10.3346/jkms.2008.23.4.586
This phase II study evaluated the efficacy and safety of combination chemotherapy with paclitaxel, cisplatin, and 5-fluorouracil (5-FU) in advanced gastric cancer. Patients with histologically confirmed gastric adenocarcinoma were eligible... -
- CITED
-
- Close
- SHARE
-
- Close
- S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
-
Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC
- KMID: 1382660
- Korean J Intern Med.
- 2008 Mar;23(1):37-41.
- doi: 10.3904/kjim.2008.23.1.37
S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1... -
- CITED
-
- Close
- SHARE
-
- Close
- Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
-
Jeong JH, Cho BC, Shim HS, Kim HR, Lim SM, Kim SK, Chung KY, Islam SM, Song JJ, Kim SY, Kim JH
- KMID: 1777495
- J Korean Med Sci.
- 2013 Jul;28(7):1005-1014.
- doi: 10.3346/jkms.2013.28.7.1005
Transglutaminase 2 (TG2), a cross-linking enzyme, is involved in drug resistance and in the constitutive activation of nuclear factor kappa B (NF-kappaB). We investigated the association of non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
-
Ku JY, Lee JZ, Ha HK
- KMID: 2344111
- Korean J Urol.
- 2015 Oct;56(10):689-694.
- doi: 10.4111/kju.2015.56.10.689
PURPOSE: To investigate the efficacy of androgen deprivation treatment (ADT) between continuous and intermittent ADT. MATERIALS AND METHODS: Between January 2006 and May 2015, 603 patients were selected and divided into... -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
-
Moon DC, Lee HS, Lee YI, Chung MJ, Park JY, Park SW, Song SY, Chung JB, Bang S
- KMID: 2374156
- Yonsei Med J.
- 2016 Sep;57(5):1124-1130.
- doi: 10.3349/ymj.2016.57.5.1124
PURPOSE: Erlotinib-gemcitabine combined chemotherapy is considered as the standard treatment for unresectable pancreatic cancer. This study aimed to determine the clinical factors associated with response to this treatment. MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
-
Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK
- KMID: 1785799
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S115-S121.
- doi: 10.3346/jkms.2007.22.S.S115
This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel/cisplatin chemotherapy in patients with metastatic or recurrent gastric cancer that had failed 5-fluorouracil/platinum-based chemotherapy. Thirty-two patients with... -
- CITED
-
- Close
- SHARE
-
- Close
